Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Coronavirus vaccine
DCGI Approves 4th COVID Vaccine For Emergency Use Among Those Under-18
New Delhi: The Drugs Controller General of India (DCGI) has granted emergency use authorization to the COVID-19 vaccine Covovax for 12-17 years age group, PTI reported on Wednesday quoting official sources.
Covovax, the Indian version of…
Serum Institute Seeks Covovax Vaccine Approval For 12-17 Year Olds
Pune: Serum Institute of India (SII) has sought emergency use authorisation (EUA) for its COVID-19 vaccine Covovax for the 12-17 age group.
Prakash Kumar Singh, Director, Government and Regulatory Affairs at SII, stated in the application…
DCGI Approves Corbevax Vaccine For Emergency Use Among 12-18 Age Group
New Delhi: Drugs Controller General of India (DCGI) on Monday approved Biological E’s Covid-19 vaccine Corbevax for emergency use among children aged 12-18 years.
The Hyderabad-based pharmaceutical company’s vaccine had earlier received…
COVID Vaccination: Aadhaar Not Mandatory On CoWIN, Govt Tells SC
New Delhi: The Union government told Supreme Court on Monday that Aadhaar card is not mandatory to register for vaccination on CoWIN portal.
The Ministry of Health and Family Welfare submitted to a bench of Justices DY Chandrachud and…
COVID Vaccine: Single-Dose Sputnik Light Granted Emergency Use Approval In India
New Delhi: Sputnik Light, Russia’s single-dose COVID-19 vaccine, was on Sunday granted emergency use approval in India by Drugs Controller General of India (DCGI).
Developed by Russia’s Gamaleya Center, Sputnik Light is built on a human…
Govt To Purchase 5 Crore Doses Of Corbevax Vaccine; Will It Be Used As Booster?
New Delhi: The Union government has placed an order with Biological E to purchase 5 crore doses of Corbevax COVID-19 vaccine.
The cost of each dose is Rs 145, excluding GST, PTI reported quoting official sources.
There was speculation…
Bharat Biotech Gets Nod For Intranasal Booster Dose Trials Of COVID Vaccine
New Delhi: Bharat Biotech on Friday received approval from the Drugs Controller General of India (DCGI) to conduct its intranasal COVID-19 booster dose trials in India.
The trials are likely to be conducted at nine locations across the…
Price Of Covaxin, Covishield Likely To Be Capped At Rs 275 Per Dose
New Delhi: The price of Covishield and Covaxin may come down substantially after the government grants full market authorization to the companies.
According to a PTI report, the price of Covishield and Covaxin is likely to be capped at Rs…
CoWIN Upgraded: Now, 6 People Can Register From One Mobile Number
New Delhi: The CoWIN portal has been upgraded and will now allow six members to be registered for vaccination from one mobile number.
The CoWIN platform, which was introduced last January, had so long facilitated registration of four…
COVID Vaccine Study: 30% People Lose Immunity After 6 Months
Hyderabad: With India launching the precautionary third dose of COVID-19 vaccine after a nine-month gap, the question of how effective the vaccine is, has resurfaced.
More so as the country is in the midst of a third wave of COVID-19…